Microtube Array Membrane (MTAM) based Hollow Fiber Assay (HFA)- Anti-cancer drug screening solution for personalized medicine and preclinical drug development.

Based on the hollow fiber assay  developed by the  US National Cancer Institute (NCI), and combined with the novel Microtube Array Membrane delivers anti-cancer drug solutions for personalized cancer treatment and commercial anti-cancer drug R&D; capable of being applied to a wide range of anti-cancer drugs including Immuno-Checkpoint Blockers (ICBs) under combination therapy settings

Our screening range of services brings unprecedented accuracy and translatability, at a fraction of the time and cost of conventional screening solutions.